TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 33 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,547,000 | +64.6% | 172,307 | 0.0% | 0.12% | +93.4% |
| Q2 2016 | $1,547,000 | -2.9% | 172,307 | 0.0% | 0.06% | -10.3% |
| Q1 2016 | $1,594,000 | -26.6% | 172,307 | 0.0% | 0.07% | -22.7% |
| Q4 2015 | $2,173,000 | -3.2% | 172,307 | 0.0% | 0.09% | +1.1% |
| Q3 2015 | $2,245,000 | -40.3% | 172,307 | 0.0% | 0.09% | -30.4% |
| Q2 2015 | $3,760,000 | -17.8% | 172,307 | -23.8% | 0.12% | -15.5% |
| Q1 2015 | $4,573,000 | – | 226,064 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |